• No results found

VU Research Portal

N/A
N/A
Protected

Academic year: 2021

Share "VU Research Portal"

Copied!
2
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

VU Research Portal

Targetable genetic signatures of immune evasion in lymphoma

Roemer, M.G.M.

2017

document version

Publisher's PDF, also known as Version of record

Link to publication in VU Research Portal

citation for published version (APA)

Roemer, M. G. M. (2017). Targetable genetic signatures of immune evasion in lymphoma.

General rights

Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights. • Users may download and print one copy of any publication from the public portal for the purpose of private study or research. • You may not further distribute the material or use it for any profit-making activity or commercial gain

• You may freely distribute the URL identifying the publication in the public portal ?

Take down policy

If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim.

E-mail address:

vuresearchportal.ub@vu.nl

(2)

Table of contents

Chapter 1 General Introduction 7

1.1. The Germinal Center 8

1.2. Non-Hodgkin lymphomas - DLBCL and LBCL subtypes 9 1.3. Hodgkin lymphoma 13

1.4. Role of the immune system in lymphoid malignancies 15

1.5. Immune checkpoint blockade in lymphoid malignancies 19

1.6. Outline and aims of this thesis 20

Chapter 2 Targetable genetic features of primary testicular and primary central nervous system lymphomas 25

Chapter 3 Recurrent genetic alterations of CD274 (PD-L1) and PDCD1GL2 (PD-L2) in T-cell/histiocyte rich large B-cell lymphoma 49

Chapter 4 B-cell and classical Hodgkin lymphomas associated with immunodeficiency 57

Chapter 5 PD-L1 and PD-L2 genetic alterations define classical Hodgkin lymphoma and predict outcome 75

Chapter 6 Chromosome 9p24.1/PD-L1/PD-L2 alterations and PD-L1 expression and treatment outcomes in patients with classical Hodgkin lymphoma treated with Nivolumab (PD-1 blockade) 91

Chapter 7 Classical Hodgkin lymphoma with reduced β2M/MHC class I expression is associated with inferior outcome independent of 9p24.1 status 101

Chapter 8 Discussion 115

8.1. Targetable genetic features of LBCLs 116

8.2. Chromosome 9p24.1 alterations in lymphoid malignancies 120 8.3. Immune evasion in Hodgkin lymphoma 125

8.4. Conclusions 130 Chapter 9 Appendices 135 9.1. Summary 136 9.2. Nederlandse samenvatting 141 9.3. Acknowledgements 148 9.4. List of publications 155

9.5. About the author 157

Referenties

GERELATEERDE DOCUMENTEN

Eén groep buigt zich over de aspecten die geregeld moeten zijn voordat de wolf naar Nederland komt en een andere groep bespreekt wat geregeld moet zijn op het moment dat de wolf

By not only comparing factor structures between volunteers and non-volunteers, but by also assessing whether the factor loadings and item intercepts are equal across the groups,

Further research made on small molecules targeting the PD-1/PD-L1 axis led Incyte Corporation to develop a novel group of inhibitors (Figure 23 , General Structure 13).. The

The current study examined the relationship between rumination and trauma-related symptoms in a sample of adolescent females in residential care, over and above the incidence

Where

An improved description of the virtual orbitals was used for the basis set test for the truncated interaction operator in the generalized length representation, in order to make

In dit onderzoek is gezocht naar een antwoord op de vraag: ‘Hoe kunnen particuliere eigenaren een watertoren herbestemmen tot woning rekening houdend met de cultuurhistorische

This paper describes the results obtaine~ in an attempt to extend the theory concerning optimal strategies in two person zero sum Markov games, as deve- loped